Meet a Researcher: We had the chance to interview Dr. Hui Shen, a 2016 Liz Tilberis Early Career Award grantee to get to know her! Read our interview here. OCRFA: Tell us about yourself. Dr. Hui Shen: My name is Hui Shen. I am originally from China, and had lived in Hong Kong and Los … Continued
OCRFA and Dr. Elizabeth Swisher spoke about the exciting progress being made by the Stand Up to Cancer Ovarian Cancer Dream Team! The SU2C Ovarian Cancer Dream Team, funded by OCRFA and NOCC, got to work on year ago. Dr. Swisher, a gynecologic oncologist at the University of Washington and co-leader of the Dream Team, … Continued
The National Comprehensive Cancer Network Guidelines for Ovarian Cancer can help walk you through all aspects of an ovarian cancer diagnosis. It answers questions from before a diagnosis through the whole cancer care continuum. You can use this guide as a way to learn more and go back to your doctor with questions you might … Continued
Join us in asking Congress to pass oral chemotherapy parity legislation today. This legislation will ensure that patients have access to the best chemotherapy drugs available, including many personalized therapies. Send an Action Alert to your Members of Congress Today! Why do we need this action now? The last decade has seen an explosion in … Continued
Miss USA, Deshauna Barber, joined Chad Ramsey and Lisa Mauti on Capitol Hill to meet with Members of Congress to educate them about ovarian cancer. Deshauna spoke with Members about Oral Chemotherapy Parity, asked for more research and awareness, and let them know just how important our community is.
Reps. Sean Duffy (R-WI) and Rosa DeLauro (D-CT) to speak at briefing on the state of ovarian cancer in the United States Watch the Briefing WASHINGTON, D.C. — Today, Reps. Sean Duffy and Rosa DeLauro, both of whom had personal experiences with ovarian cancer, will celebrate the first anniversary of the Congressional Ovarian Cancer Caucus … Continued
(October 5, 2016) A new analysis published in the American Journal of Obstetrics and Gynecology determined the impact of gynecologic surgeon volumes on patient outcomes. Reviewing fourteen studies that involved over 700,000 women, the researchers found that low-volume surgeons (categorized as those performing the procedure approximately once a month or less) were found to have … Continued
(October 5, 2016) A team of researchers, including senior author and former OCRFA grantee Rugang Zhang, PhD, have been studying the relationship between PD-1 and PD-L1, a protein and an accompanying molecule, and t-cells, which are a body’s natural defense against tumor growth. PD-L1 can be found on both cancer cells and healthy cells but, … Continued
We are so excited to announce that Kiehl’s will be donating $25,000 to OCRFA during September. We are thankful for their continued support of the ovarian cancer community and commitment to change the future of ovarian cancer! #30DaysofTeal Visit Kiehl’s LifeRide for OCRFA in Los Angeles! for event details.
Research Advocate, Annie Ellis, recently attended the Biennial Ovarian Cancer Research Symposium presented by the Rivkin Center for Ovarian Cancer and the American Association for Cancer Research. Read her report, check out a poster on Beyond RECIST 1.1 and a poster on MAGENTA-Making Genetic Testing More Accessible.
Let’s take a minute today to thank our doctors, our nurses, and all of our medical professionals who help us and our loved ones with ovarian cancer. The ovarian community salutes these amazing people working on the front lines every day. #30DaysofTeal Today’s post is sponsored by Immunogen
Are you ready to look for a clinical trial? OCRFA offers two great resources: Carebox and Cure Forward. Carebox provides a comprehensive yet simplified system for women to find and link to clinical trial options for ovarian cancer. Cure Forward provides access to clinical trials and targeted treatment options, and can help you understand precision … Continued
Get email updates about research news, action alerts, and ways to join the fight.
